For Litigation Funders

Litigation Funders and Mass Tort Advertising

Last reviewed 2026-05-31 by Jacob Malherbe.

Quick Facts

What MTAA provides funders	Real-time ad-spend & cost-per-signed-retainer dashboards; view-access to Meta Business Manager; full cost-plus transparency; chain-of-custody documentation per claimant; co-counsel introductions
Reporting cadence	Real-time dashboard with live spend and signed-retainer counts; weekly written summaries; monthly portfolio reports for multi-tort deployments
Independent ad-spend verification	View-only Meta Business Manager access for the funder on funded campaigns
Pricing model	Cost-plus: actual Meta ad spend + 15% management fee + $100 per signed retainer to CloudIntake. No per-lead, no per-case markup, no concealed margins.
Funder confidentiality	MTAA does not publicly name funder counterparties. Existing funder relationships and references available privately under NDA.
Co-counsel introductions	MTAA facilitates introductions between funders and plaintiff law firms in MTAA's network running active torts that fit the funder's capital deployment thesis
Total Meta ad spend managed	$250M+ since 2015
Plaintiff firms served	600+
Distinct mass torts run	100+
Intake model	CloudIntake flow-through self-service qualification; no outbound calls; no outbound-call TCPA exposure
Founder	Jacob Malherbe (15+ years; author of A Lawyer's Guide to Mass Torts and The Facebook Effect for Lawyers)

Why most litigation funders are underweight on understanding what they are actually funding

Plaintiff law firms have lived inside mass tort operations for years. They have absorbed, by exposure, the operational realities of how claimants get acquired, how qualification works, and what the regulatory exposure looks like in practice when defense counsel starts probing recruitment chains in MDL discovery.

Litigation funders, as a class, have not. The funder is one step removed from the claimant, two steps from the defendant, and three steps from the actual operational mechanism that produced the funded inventory. The funder is evaluating a capital deployment opportunity. The questions the funder is trained to ask are about expected settlement value, expected timeline to resolution, MDL leadership positioning, jurisdiction selection, and fee multiples. These are the right questions for evaluating the litigation thesis.

The questions the funder is generally not trained to ask are about the upstream operational mechanism that produced the claimant inventory in the first place. What ad ran? Where did the claimant come from? Who qualified them? What did the qualification consist of? Who has the documentation? Will the documentation survive a defense subpoena in discovery? These questions feel like they belong to the law firm. In reality, they determine whether the funder's collateral will hold up in two years when the MDL settlement administrator starts reviewing claims for disqualification.

The structural problem is that the operational risk in mass tort capital deployment is concentrated at the production layer — where the advertising and the intake happen — and that layer is precisely the part of the value chain that funders have the least direct visibility into. The funder hears, from the firm, that "the cases came from advertising." The firm hears, from the agency or the broker, that "the cases came from qualified advertising on social platforms." Each hand-off compresses the operational detail until what the funder is actually evaluating is a count of signed retainers and an aggregate cost basis — with no view into the recruitment chain that produced them.

This is the gap that historically explodes in mass tort cycles. Funders who deployed capital into transvaginal mesh inventory in the early 2010s discovered, when the Buzzell testimony surfaced in the AMS MDL, that some of their funded claims had recruitment origins the funded firms could not credibly defend. Settlement valuations on those blocks dropped. Some funded firms had to refile, restructure, or accept impaired returns. The funders' due diligence at deployment had not included the production-layer questions. By the time the questions mattered, the answers were already locked in by recruitment decisions the funder had no input on.

The pattern is happening again, in real time, in the Uber MDL 3084 in the Northern District of California. Plaintiffs are being dismissed in batches by Judge Charles Breyer for producing fabricated ride receipts to qualify into the MDL — 27 dismissals in one wave in early 2026, with another 13 in the next motion, with subpoenas walking up the chain to the third-party fake-receipt template companies, with separate RICO suits filed by Uber against plaintiff law firms and the lead-generation operations that funded the staged claims. The plaintiff firms whose retainers are being dismissed are absorbing the regulatory consequence directly on their bar cards. The litigation funders who deployed capital into those firms' Uber MDL portfolios are absorbing it indirectly — through impaired collateral, settlement-administrator claw-back, and reputation contagion that affects the funded firm's posture in every other MDL it appears in.

The defensive answer to this risk is not more legal review of the litigation thesis. It is operational transparency into how the claimant inventory was actually produced — at the ad layer, at the landing page layer, at the qualification layer, and at the retainer execution layer. That is what this page is about.

The "one price per case" pitch — and what it actually transfers to the funder

The most common pricing model funders encounter when evaluating mass tort capital deployment is a fixed price per signed case. A broker, or a buying-cases operation, quotes the funded firm a number: $1,800 per signed Video Game Addiction retainer, $3,200 per signed Social Media Addiction retainer, $4,000 per signed Roblox sexual abuse retainer. The funder funds the firm; the firm buys the cases; the inventory loads into the firm's MDL filing; the funder books the capital deployment against expected MDL settlement value.

The pricing is appealingly simple. One number. One transaction. Predictable cost basis. No need to understand Meta Business Manager. No questions about creative or pixel infrastructure or qualification flow design. The funder writes the check, the firm buys the inventory, and the operational complexity is delegated to the broker or the upstream operation that produced the cases.

What the funder is actually paying for in that pricing model: production cost plus broker margin plus risk transfer. The funder typically does not see the production cost — that is concealed inside the per-case price. The broker margin is whatever the market will bear, which on a typical mass tort runs 3x to 4x what producing the same claimants through cost-plus advertising would actually cost. The risk transfer is the part the funder generally does not understand: the broker is being paid not just for the inventory but for accepting (and then immediately offloading, onto the buying firm) the chain-of-custody exposure of the recruitment that produced it.

Specific market comparisons as of May 2026:

• Video Game Addiction: MTAA cost-plus production at $350-$400 per signed retainer; buying-cases broker price at approximately $1,600. The broker premium is roughly 4x production cost.
• Social Media Addiction: MTAA cost-plus production at $600-$800 per signed retainer; buying-cases broker price at approximately $2,750. The broker premium is roughly 3.5x to 4x production cost.
• The same ratios hold across most active torts. The 3-4x broker multiple is the steady-state premium for inventory the funder cannot audit and the firm did not direct.

On a 1,000-case Video Game Addiction MDL block, the funder backing the buying-cases firm is paying approximately $1.6 million for the inventory. The same 1,000 cases produced through cost-plus advertising would have cost approximately $400,000-$460,000 (setup + Meta spend + 15% management fee + CloudIntake fees). The difference — roughly $1.14 million to $1.20 million — is the broker premium the funder paid for the privilege of not having visibility into how the cases were produced.

That premium is not the funder's only cost in the broker model. The broker model also concentrates the chain-of-custody risk on the buying firm — and therefore on the funder's collateral. When the MDL settlement administrator starts reviewing claims for disqualification, the disqualified claims are the ones with unverifiable recruitment origins. When defense counsel subpoenas the firm's intake records in discovery, the records that don't exist are the records the broker never produced for the inventory the firm bought. The firm absorbs the discovery hit, the settlement-administrator claw-back, the bar-disciplinary exposure, and the reputation impact. The funder absorbs the collateral impairment.

The economic comparison gets worse, not better, when the risk-adjusted return is calculated. A funder who deployed $5 million across 3,125 cases at the broker rate ($1,600 each) and who experiences a 15% disqualification rate at the settlement-administrator review (a not-uncommon outcome for inventory with unauditable recruitment chains) ends up funding 2,656 surviving cases against a $5 million capital base — an effective per-case cost basis of $1,883 even before broker premium. A funder who deployed the same $5 million through a cost-plus operation at $400 per case would have funded 12,500 cases, of which (with chain-of-custody documentation surviving challenge) the disqualification rate would be near zero, leaving the effective per-case cost at $400. The risk-adjusted return on the cost-plus deployment is more than 4x the broker deployment.

None of this is theoretical. It is the structural economics of how mass tort capital deployment actually works — and the structural reason that funders who understand the production layer end up requiring cost-plus operational architecture from the firms they fund.

What MTAA provides litigation funders directly

The MTAA funder model is a layered transparency operation. The funder is not buying inventory and the funder is not running operations. The funder is deploying capital into a plaintiff law firm running mass tort campaigns through MTAA. What MTAA provides directly to the funder is the operational visibility and documentation infrastructure that allows the funder to verify, in real time, that the capital is being deployed against actual advertising producing actual qualified claimants on auditable chain-of-custody.

Real-time ad spend and cost-per-signed-retainer dashboard.

The funder receives view-access to a live dashboard covering every funded campaign. The dashboard reports actual Meta ad spend deployed since the campaign launched, current 30-day cost per signed retainer, current month-to-date cost per signed retainer, current qualification rate, signed-retainer count by tort, and projected end-of-month spend and signed-retainer counts. The data updates continuously. There is no monthly batch report. There is no "we'll send you a summary after the quarter closes." A funder logging into the dashboard at any moment sees the current state of the funded campaigns.

For multi-tort funder deployments, the dashboard aggregates across torts and presents portfolio-level views — total capital deployed across the funded firm's campaigns, blended cost per signed retainer across the portfolio, allocation by tort, performance trends by tort. The funder can also drill into a specific tort and see the campaign-level operational detail.

View-access to Meta Business Manager.

The funder can be granted view-only access to MTAA's Meta Business Manager on the funded firm's specific campaigns. This is the independent verification mechanism for the ad-spend numbers shown in the MTAA dashboard. The funder can log into Meta directly, audit campaign-level spend, see the actual ads that ran, see the actual targeting that was used, and verify that what MTAA reports as ad spend matches what Meta records as ad spend. There is no daylight between what MTAA shows the funder and what Meta would show under independent audit.

The relevance of this is structural. Cost-plus pricing only works as a transparency mechanism if the underlying ad-spend numbers are independently verifiable. Meta Business Manager view-access is what makes the cost-plus pricing model actually auditable rather than nominally auditable. A funder who deploys capital into a campaign run by an operation that will not provide Meta Business Manager view-access is deploying capital into an opaque cost structure, regardless of what pricing model the operation claims to use.

Chain-of-custody documentation on every signed claimant.

For every signed claimant the funded campaigns produce, MTAA preserves and makes available to the funded firm — and on the firm's authorization, to the funder — a complete documentary trail. The originating Meta ad creative and the targeting parameters that produced the impression. The firm-branded landing page the claimant viewed, including the disclosures and the TCPA consent language presented. The structured qualification question-and-answer record. The TCPA consent confirmation. The retainer execution record with timestamp, IP, and electronic signature.

This documentation is what protects the funded firm's bar card against MDL claw-back, defense-counsel discovery in bellwether trials, federal RICO exposure (as currently active in the Uber MDL), and bar-disciplinary inquiry from the state bars where the claimants reside. The same documentation, by extension, protects the funder's collateral — because the funder's collateral is the inventory of signed retainers and the firm's continued ability to practice law. Impair either of those and the funder's deployment is impaired.

Cost-plus pricing — what the funder is actually paying.

The MTAA cost stack is four components, all visible, all verifiable. (1) Setup: $1,000 per tort, one-time. The funded firm pays this at the point a new tort is onboarded; it is a fixed and predictable line item. (2) Meta ad spend at actual cost, verifiable through Meta Business Manager. (3) MTAA management fee: 15% of Meta ad spend. (4) CloudIntake: $100 per signed retainer, charged only when a qualifying claimant e-signs the firm's retainer.

The funder can predict the total deployment cost from inputs: a $1 million ad budget on Video Game Addiction at a current cost per signed retainer of $375 deploys approximately 2,667 signed retainers (or whatever the actual current CPS produces) and totals approximately $1.42 million in all-in cost ($1M ad spend + $150K management fee + ~$267K CloudIntake + ~$1K setup). Every line is independently verifiable. The funder can audit the deployment from the dashboard, the Meta Business Manager view, the CloudIntake retainer records, and the funded firm's CRM — and every audit ties out to the same numbers.

Co-counsel introductions across MTAA's plaintiff law firm network.

MTAA has working relationships with 600+ plaintiff law firms across the United States, including many firms in MDL leadership positions on active torts. For a funder evaluating which firms to deploy capital into on a specific tort, MTAA can facilitate introductions to firms in the network that match the funder's deployment thesis — by tort, by jurisdiction, by leadership position, by case-portfolio composition, by the funder's preferred firm-size profile.

This is a relationship layer the funder does not get from buying inventory through a broker. The broker delivers signed cases; the broker does not introduce the funder to firms whose mass tort portfolios match the funder's strategic positioning. MTAA's plaintiff bar network — built over 15+ years — provides the funder with a curated path to the firms running the torts the funder wants to fund.

Funder confidentiality.

MTAA does not publicly name funder counterparties. Funders working with MTAA are listed under NDA. References from existing funder relationships are available privately to qualified prospective funder counterparties under the same NDA structure. The reason the page does not name funders is that funders prefer confidentiality as a matter of operational posture, and MTAA respects that preference uniformly.

The funder due diligence framework — six diagnostic questions

A litigation funder evaluating any mass tort advertising operation should apply the same six diagnostic questions to every candidate. These are the production-layer questions that funders have historically been underweight on. Honest answers separate operations the funder's collateral can rely on from operations whose recruitment chains will not survive MDL discovery.

1. Can the funder independently verify actual Meta ad spend on the funded campaigns?

The operational question is whether view-access to the relevant Meta Business Manager is available to the funder. The structural question is whether the pricing model the operation uses produces independently verifiable ad-spend numbers. Cost-plus pricing with Meta Business Manager view-access satisfies both. Cost-per-case pricing with no view-access satisfies neither. An operation that refuses to grant view-access to Meta Business Manager on funded campaigns — under any pretext — is an operation whose cost structure the funder cannot audit. Capital deployed there is capital deployed against a number the funder must trust without verification. This is the single most important due diligence question for a funder, and the one most likely to be answered evasively by operations the funder should not back.

2. How is intake conducted, and what does that imply about coaching risk and TCPA exposure?

The intake mechanism — the conversion step from advertising response to signed retainer — is where chain-of-custody fails most often in mass tort. Call-center intake with outbound specialist calls to claimants creates outbound-call TCPA exposure (every unauthorized outbound call is a potential TCPA class action), creates depositional surface area where defense counsel can probe specialists for coaching, and creates documentation gaps when scripts drift or recordings are incomplete. Offshore call centers compound all three risks because the operational standards, retention of specialists, and quality of recordings tend to be lower.

Flow-through self-service qualification (the model CloudIntake operates) eliminates these failure modes structurally. The claimant answers structured questions on their own with no specialist on the line to coach. There are no outbound calls during qualification, so no outbound-call TCPA exposure. The qualification record is a deterministic question-and-answer artifact identical for every claimant. A funder backing a firm whose intake architecture is flow-through is backing a firm whose claimant origins will hold up under MDL discovery. A funder backing a firm whose intake architecture is offshore call center is backing a firm whose claimant origins are an open question every time a defense subpoena lands.

3. What chain-of-custody documentation exists on every funded claimant?

The required documentary trail per claimant: originating ad creative and targeting; firm-branded landing page record with disclosures and TCPA consent presented; structured qualification record; TCPA consent confirmation; retainer execution log. If the operation can produce all five on demand for any claimant in the funded portfolio, the funder's collateral has the documentation it needs to survive MDL claw-back, defense discovery, and bar-disciplinary inquiry. If the operation cannot — if any of the five is unavailable, or available only in summary form, or "we don't generally provide that level of detail" — the funder's collateral is unverifiable and the inventory should be priced accordingly (or declined).

4. Does the pricing model conceal or reveal the underlying production cost?

Cost-plus reveals. The funder sees actual Meta spend, a stated management fee percentage, and a per-signed-retainer intake fee. Three numbers. All verifiable. Cost-per-case conceals. The funder sees one number per case. The funder does not see how much of that number is actual production cost, how much is broker margin, and how much is the broker's risk-transfer premium for accepting (and reselling) the chain-of-custody exposure of the recruitment. A funder defaulting to cost-per-case pricing is defaulting to opacity at the precise layer where capital risk concentrates. The economics will sometimes look acceptable on the deployment day; they will not look acceptable when the MDL settlement administrator starts reviewing claims with unauditable origins.

5. What is the bar-card risk profile of the funded firm?

The funder's collateral is two things: the inventory of signed retainers, and the funded firm's continuing ability to practice law. The inventory can be impaired by MDL claw-back of disqualified claims. The firm's ability to practice can be impaired by bar-disciplinary action stemming from advertising the firm authorized but cannot defend. The operational architecture that protects both is the same — every ad approved in writing by the firm before going live, every landing page approved in writing, flow-through qualification with no coaching risk, full chain-of-custody documentation per claimant. The funder should verify, before deployment, that the funded firm operates under this architecture. A firm that runs advertising through an operation that does not require firm approval on every ad and every landing page is a firm whose bar card is exposed on every campaign and every variant — and therefore a firm whose funder is exposed to the consequence.

6. What is the reporting cadence and granularity post-deployment?

A funder deploying capital into mass tort advertising needs visibility that updates faster than the campaign moves. Mass tort tactics shift weekly — creative cycles, audience refinements, qualification-flow tuning, response to MDL developments, response to competitive spend. A monthly summary report is a lagging indicator. Real-time dashboards reporting current spend, current cost per signed retainer, current qualification rates, and current signed-retainer counts by tort are the operational standard. A funder whose only reporting visibility is monthly batch summaries is a funder whose deployment is opaque between report deliveries — which is when the deployment most often goes off-strategy.

Capital deployment worked examples — May 2026 rate card

Three illustrative scenarios using current MTAA rate card numbers. These are stylized to show the deployment math; actual results vary by month, campaign performance, and firm-specific factors.

Scenario 1: $1M deployed into Video Game Addiction.

Current 30-day cost per signed retainer on VGA through MTAA: $350-$400 (using $375 mid-point for the example). $1M deployed across the cost-plus stack:

• Setup (one-time, if VGA is a new tort for the funded firm): $1,000
• Meta ad spend deployed: $863,000
• MTAA 15% management fee on Meta spend: $129,450
• CloudIntake at $100 × signed retainers produced (assume ~2,300 signed retainers from $863K spend at $375 CPS): $230,000
• Total deployment: ~$1,223,450 (the ~$223K above the headline $1M reflects the management fee and CloudIntake fees added to ad spend; a $1M ad-spend budget produces roughly 2,300 signed retainers at this CPS level)
• For a strict $1M deployment ceiling, the math runs in reverse: $1M total cap divided by all-in cost structure yields approximately $705K Meta spend + $105K management fee + $189K CloudIntake + $1K setup = ~1,884 signed retainers

Comparable broker market price for 1,884 signed VGA retainers at $1,600/case: $3,014,400. Same 1,884 retainers through cost-plus: $1M. Cost-plus advantage: ~3x the inventory per dollar deployed.

Scenario 2: $5M deployed across a multi-tort portfolio.

A funder deploying $5M into a funded firm running three torts simultaneously — Video Game Addiction, Social Media Addiction, and PFAS — at the funded firm's chosen allocation (assume 40/40/20). Setup cost: $3,000 (one-time, three torts × $1,000). Allocations:

• $2M into Video Game Addiction at $375 CPS: ~3,765 signed retainers produced (after 15% management + $100 CloudIntake + setup)
• $2M into Social Media Addiction at $700 CPS: ~2,015 signed retainers produced
• $1M into PFAS at $1,500 CPS: ~470 signed retainers produced
• Portfolio total: ~6,250 signed retainers across three torts on $5M deployment

The dashboard reports portfolio-level views and tort-level drilldowns. Meta Business Manager view-access covers all three campaigns. Chain-of-custody documentation is preserved per claimant across all three torts. The funder can audit any individual signed retainer in the portfolio and see the full documentary trail.

Scenario 3: Acceleration scenario on a heating tort.

A funder deploying additional capital into a tort that is accelerating mid-deployment (an FDA action lands, an MDL judge sets a bellwether trial date, a settlement framework emerges). The MTAA operational architecture allows additional spend authorization to deploy within days, against an already-trained pixel and an already-running CloudIntake qualification flow.

The contrast: a funder with the same thesis deployed into a multi-vendor operation (separate media buyer, separate intake call center, separate landing-page vendor) typically requires weeks of vendor coordination to scale. The acceleration window — typically 30 to 60 days from MDL development to peak competitive spend — closes before the deployment can move. The same capital that produces 6,000 signed retainers during the window produces 1,500 outside of it.

The structural advantage MTAA provides on acceleration scenarios is the integrated media-and-intake stack. The funder authorizes additional capital; the funded firm authorizes the spend increase; MTAA scales the campaign on the same day. There is no vendor coordination delay because there is no second vendor to coordinate with.

Tort selection from a funder perspective

Not every active tort is appropriate for funded deployment. The criteria a funder should apply to tort selection are different from the criteria a plaintiff firm applies — the funder is sensitive to predictability of returns and capital-protection structure in a way the firm absorbing the underlying litigation work is not.

Funder-appropriate torts.

Established MDLs with active leadership, predictable cost-per-signed-retainer profiles, and clear settlement frameworks emerging or already in place. Active torts on the May 2026 MTAA rate card that meet this profile: Video Game Addiction (active MDL leadership, established CPS profile at $350-$400, trained pixel with 275,000+ lead events and 100,000+ signed retainers); Social Media Addiction (active MDL, established CPS at $650, qualification rate at 9% indicating real qualification gate); Transvaginal Mesh revision-surgery cases ($900 CPS, MDL leadership established, settlement frameworks well-understood from prior mesh cycles); PFAS (multiple active MDLs, $1,200-$1,800 CPS, defendant-defendant settlement dynamics emerging).

Torts requiring funder due diligence beyond standard.

Origination torts and emerging litigation theories. Sports Betting Addiction (active but the MDL infrastructure is still consolidating; CPS at $350 looks favorable but settlement-value modeling carries higher uncertainty than the established addictive-design torts). Roblox/Discord Sexual Abuse and Church Sexual Abuse (high-conviction but phone-first intake at $2,000-$3,000 CPS, with the deployment math depending heavily on settlement valuation assumptions that vary widely by jurisdiction). Ethylene Oxide (geographically constrained, CPS variance from $700-$1,800 by facility location requires geographic modeling). These can be appropriate for funder deployment but require additional analysis of the specific MDL posture, leadership composition, and settlement-modeling assumptions before capital is committed.

What MTAA tells funders about tort selection.

The honest position is that not every active tort produces a deployment profile consistent with every funder's capital protection thesis. The MTAA team discusses tort selection with funders as a function of the funder's specific risk tolerance, holding-period preference, and portfolio composition — not as a uniform recommendation. The discussion happens directly between the MTAA team and the funder before deployment, not through marketing materials. The rate card publishes CPS numbers; the strategic tort-selection conversation happens privately.

The Buzzell precedent and the Uber MDL escalation — what funders need to understand

The reason this page leads with the capital-protection argument rather than the standard funder-marketing pitch is that there is a current, active, escalating federal court pattern that puts funded firms — and their funders' collateral — directly in the line of fire if the recruitment-chain documentation is not defensible.

The Buzzell baseline.

In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325 in the Southern District of West Virginia, plaintiff Judy Buzzell testified that she had been contacted multiple times by a call center about her transvaginal mesh implant. According to the testimony referenced in court filings and Pretrial Order #215 (2016), the callers told her there were problems with her sling, implied a recall, encouraged her to seek revision surgery, and steered her toward retaining counsel. Defense counsel used her testimony as a centerpiece argument that the broader plaintiff pool had been recruited through telemarketing solicitation rather than through legitimate medical or legal channels — and made it a recurring lever on champerty/maintenance doctrine, on discovery into plaintiff-recruitment methods, and on the validity of claims throughout the AMS MDL.

The MDL ultimately settled (in waves running into the billions across J&J Ethicon, AMS, and other mesh defendants), but settlement valuations on blocks of claims with unclear recruitment origins were systematically discounted. Funders backing firms with affected inventory absorbed the valuation hit in their realized returns. The funders who had done production-layer due diligence at the front end (before the Buzzell testimony surfaced) and whose funded firms operated under documented chain-of-custody architecture took less of the hit. The funders who had not absorbed more of it.

The Uber MDL 3084 escalation — currently active.

In re: Uber Technologies, Inc., Passenger Sexual Assault Litigation, MDL No. 3084 in the Northern District of California, Judge Charles Breyer required every plaintiff to produce a bona fide Uber ride receipt connecting them to the alleged incident. Uber alleged and the court agreed that dozens of plaintiffs submitted phony, altered, or outright fabricated receipts. Some had been generated by third-party fake-receipt apps and websites that exist specifically to generate look-alike documentation.

The court has dismissed dozens of plaintiffs from the MDL on these grounds — initial waves in 2026 hitting 27 plaintiffs at once, with additional motions targeting another 13 and counting. Judge Breyer has issued subpoenas to the companies that produce the fake-receipt templates and consolidated the subpoena enforcement actions into the MDL itself. Uber has filed separate RICO lawsuits against plaintiff law firms, medical providers, and lead-generation operations alleging staged claims and inflated injuries across the rideshare litigation landscape.

What this pattern means for funders.

The Uber escalation establishes that defense counsel and federal judges in modern mass tort MDLs will dismiss plaintiffs, issue subpoenas walking up the recruitment chain, and file RICO suits against plaintiff firms and lead-generation operations when the underlying claims are produced through indefensible recruitment methods. The consequence flows through the firm of record (whose bar card is exposed and whose name is on the dismissal orders) to the funder backing that firm (whose collateral is impaired by every disqualified claim, by every RICO-related operational disruption, and by the reputational contagion that affects the funded firm's posture in every other MDL it participates in).

The defensive posture that protects funded firms — and the funder's collateral — is the same posture the For Lawyers page describes: every ad approved in writing by the firm before going live, every landing page approved in writing, qualification conducted through flow-through self-service architecture with no coaching opportunity and no outbound-call TCPA exposure, and complete chain-of-custody documentation preserved for every claimant. A funder whose deployed capital is concentrated in firms operating under this architecture is a funder whose collateral can survive the next Buzzell-style discovery wave or the next Uber-style RICO escalation. A funder whose deployed capital is concentrated in firms operating outside this architecture is a funder whose collateral will be impaired by the next wave — whatever specific tort it surfaces in.

Frequently Asked Questions

Glossary

Capital deployment

The act of a litigation funder committing financial capital to a plaintiff law firm to fund mass tort campaign activities (advertising, intake, case development) in exchange for a contractual return tied to settlement outcomes.

Chain of custody

The documented trail of how a specific claimant became a client of the firm of record: the originating advertisement, the targeting parameters, the landing page presented, the qualification answers, the TCPA consent capture, and the retainer execution. Defensible chain of custody is auditable from first ad impression through retainer signature. For litigation funders, this is the documentation that protects collateral against MDL claw-back and defense-counsel discovery.

Champerty

The legal doctrine prohibiting third parties from financing litigation in exchange for a share of the proceeds when the financing party has no legitimate interest in the underlying dispute. A centuries-old doctrine still enforced by every state bar and routinely invoked by defense counsel in mass tort to challenge the legitimacy of plaintiff recruitment. Recruitment-chain failures are the trigger that creates champerty exposure for both the funded firm and the funder backing it.

CloudIntake

MTAA's claimant qualification operation. Flow-through self-service qualification with no outbound calls during qualification, no specialist coaching opportunity, and no outbound-call TCPA exposure. Charges $100 per signed retainer, paid exclusively on performance.

Collateral impairment

In the context of litigation funding, the reduction in expected return on a capital deployment caused by factors that reduce the value of the funded firm's signed retainer inventory. Sources include MDL disqualification of claims with unauditable recruitment origins, settlement-administrator claw-back, defense valuation discount on blocks with chain-of-custody gaps, and bar-disciplinary action against the funded firm impairing its ability to deliver on remaining inventory.

Cost-per-case (CPC) pricing

A pricing model in which the advertising operation or broker charges a fixed price per signed retainer delivered, with the underlying advertising and intake costs concealed from the buying firm and (downstream) from the funder backing the firm. The pricing model most associated with chain-of-custody risk concentration. Funders defaulting to cost-per-case are defaulting to opacity at the layer where capital risk accumulates.

Cost-plus pricing

A pricing model in which the advertising operation charges actual Meta ad spend (verifiable through Meta Business Manager) plus a stated management fee. The principal-agent commercial structure required under common law for marketing agencies acting on behalf of clients. MTAA's pricing: cost plus 15% management fee on Meta spend, plus $100 per signed retainer to CloudIntake, plus $1,000 per-tort setup.

Cost per signed retainer (CPS)

The primary unit-economics metric for mass tort advertising. Total advertising and intake cost required to produce one signed claimant retainer agreement, divided by the number of signed retainers a campaign produced. Published monthly on MTAA's rate card. For funders, the operational metric used to forecast deployment outcomes.

Due diligence (funder)

The pre-deployment evaluation a litigation funder performs before committing capital to a plaintiff law firm. Standard due diligence covers the litigation thesis, MDL posture, expected settlement timing, and firm leadership. Production-layer due diligence — historically underweight in funder practice — covers the operational architecture that produces the funded claimant inventory: ad-spend transparency, intake architecture, chain-of-custody documentation, and bar-card risk profile.

Litigation funding

Third-party financing of legal claims or claim portfolios, in which a non-party to the litigation provides capital to a plaintiff or plaintiff law firm in exchange for a contractual return tied to litigation outcomes. A regulated industry with growing regulatory attention from state bars and federal courts.

MDL (Multi-District Litigation)

Federal procedural mechanism for coordinating large numbers of related civil cases filed in multiple federal districts. Cases are transferred to a single federal court for coordinated pretrial proceedings, then returned to the originating courts for trial (with most cases resolved through global settlement in the MDL). The procedural setting where most mass tort capital deployments resolve.

Meta Business Manager view-access

View-only credentials to a Meta advertising account that allow the holder to inspect campaign spend, ad performance, targeting parameters, and creative without authority to modify or run campaigns. The independent verification mechanism for cost-plus pricing — a funder with view-access can audit ad spend directly in Meta rather than relying on agency-reported numbers.

Pixel

Meta's tracking and optimization infrastructure that captures conversion events on advertisers' campaigns and uses the accumulated event data to refine targeting. A trained pixel — one with many qualified conversion events — outperforms a fresh pixel by a significant margin. MTAA operates tort-specific trained pixels shared across all participating plaintiff firms running each active tort.

Real-time dashboard

A reporting interface that updates continuously with current campaign performance data — ad spend deployed, signed-retainer counts, cost per signed retainer, qualification rate. The reporting cadence that allows funders to track deployment performance between scheduled reports rather than only at month-end batch summaries.

RICO (Racketeer Influenced and Corrupt Organizations Act)

Federal statute providing civil and criminal causes of action for patterns of organized criminal activity. Mass tort defendants (Uber in the current MDL 3084 escalation) have used civil RICO actions against plaintiff law firms and lead-generation operations alleging staged claims and inflated injuries. RICO exposure for funded firms is a direct collateral-impairment vector for funders backing them.

Settlement administrator claw-back

The process by which the settlement administrator in a resolved mass tort MDL disqualifies claims from the settlement pool for failing to meet documentation, qualification, or eligibility requirements. Claims with unauditable recruitment origins are systematically more likely to face claw-back. For funders, the operational risk vector that connects pre-deployment chain-of-custody decisions to post-resolution realized returns.

TCPA (Telephone Consumer Protection Act)

Federal statute regulating telemarketing, automated dialing, and unsolicited text messaging. TCPA class actions against law firms for unauthorized outbound calls or texts have been a recurring source of liability in mass tort. Flow-through qualification eliminates outbound-call TCPA exposure for the funded firm; follow-up communication operates under explicit TCPA consent captured on the landing page.

Tort acceleration window

The period (typically 30 to 60 days) following a triggering event in a mass tort — an FDA action, a bellwether trial date, a settlement framework announcement — during which competitive ad spend rises sharply and signed-retainer production peaks. The window during which integrated media-and-intake operations capture disproportionate share. Funders deploying capital into multi-vendor operations typically miss the window because of vendor coordination delays.

View-only access

Credentials that grant the holder authority to inspect data and configuration without authority to modify it. For funders, view-only access to Meta Business Manager and the MTAA dashboard provides verification authority without operational control — the appropriate posture for capital-protection due diligence.

Have a capital deployment conversation with MTAA

30-minute call covering current funded campaigns at MTAA, MTAA's plaintiff law firm network, the funder's deployment thesis, the active tort rate card, and the operational reporting architecture MTAA provides. Funder counterparties remain confidential under NDA. Book the call →

Last reviewed 2026-05-31 by Jacob Malherbe.